Speakers:

James R. Ravitz

Partner
Arent Fox LLP

Daniel A. Kracov

Partner
Arnold & Porter LLP

The Nature of the Approval Process

March 12, 2014 10:15 am

Michael Walsh

Principal and International Managing Partner
Midgard Consulting Inc.

Joseph G. Poluka

Partner
Blank & Rome LLP

James Beck

Partner
Reed Smith LLP (Philadelphia, PA)

Edward F. Glynn Jr.

Partner
Manatt, Phelps & Phillips, LLP

Geoffrey M. Levitt

Associate General Counsel Regulatory, Environmental and Global Supply
Pfizer Inc.

Co-Chairs’ Opening Remarks

March 12, 2014 8:30 am

Joseph A. Mahoney

Partner
Mayer Brown LLP

Chad A. Landmon

Partner
Axinn, Veltrop & Harkrider LLP (Hartford, CT & Washington, DC)

Donald Ware

Partner
Foley Hoag LLP

Seth A. Mailhot

Partner
Michael Best & Friedrich LLP (Washington, DC)

Stephen Terman

Principal
Olson Frank Weeda Terman Matz, PC (Washington, DC)

Linda Pissott Reig

Shareholder
Buchanan Ingersoll & Rooney PC

Jane Mathews

Assistant General Counsel
Sunovion Pharmaceuticals, Inc.

Scott Bass

Partner & Head, Global Life Sciences
Sidley Austin LLP (New York, NY)

Co-Chairs’ Opening Remarks

March 12, 2014 8:30 am

Karen Weaver

Vice-President & Associate General Counsel, Regulatory
CareFusion Corporation (San Diego, CA)

Eric D. Hargan

Shareholder
Greenberg Traurig LLP

Drugs and Biologics: Labeling

March 12, 2014 4:00 pm